News

Insulin Therapy May Prevent AFib in Diabetics With HF


 

ATLANTA — Insulin use appears to protect against atrial fibrillation in diabetic patients with heart failure, Dr. Somjot S. Brar said at the annual meeting of the American College of Cardiology.

If this initial observation in a large community-based population of patients with heart failure is subsequently confirmed by other investigators, it could very well lead to a lower threshold for switching diabetic patients from oral agents to insulin therapy. They might benefit in two ways: improved glycemic control, and protection against the most common sustained arrhythmia, added Dr. Brar of Kaiser Permanente and the University of California, Los Angeles.

He identified 28,009 patients with heart failure in a managed care data base, 45% of whom were diabetic. Thirty-eight percent of the diabetic patients with heart failure were on insulin therapy.

“These heart failure patients are similar to what most internists, family physicians, and cardiologists would see. It's not a special group like patients on a transplant list,” he noted.

Insulin users had an adjusted prevalence of atrial fibrillation that was 20% less than diabetic non-insulin users or nondiabetic heart failure patients in a multivariate logistic regression analysis. The model controlled for numerous potential confounders including age; gender; socioeconomic status; cardiovascular risk factors; and the use of statins, ACE inhibitors, and other drugs that may potentially prevent atrial fibrillation. Insulin's apparent protective effect was equally robust and consistent in men and women of all ages, according to Dr. Brar.

The nature of insulin's effects on atrial electrical activity isn't completely understood, he said.

Dr. Brar and his colleagues came up with the hypothesis that insulin use protects against atrial fibrillation in response to reports in the cardiac surgical literature suggesting that patients on insulin have a lower incidence of postoperative atrial fibrillation. A heart failure population was a logical testing ground for the hypothesis because the prevalence of the arrhythmia is so high.

Recommended Reading

Evaluate Patients With PCOS for Sleep Apnea : Women with the treatable breathing disorder had higher fasting insulin levels than those without it.
MDedge Family Medicine
Diabetics Face Highest Stroke Risk Shortly After Diagnosis
MDedge Family Medicine
Tracking FSH Annually Helps Predict Bone Density Loss in Perimenopause
MDedge Family Medicine
Continuous Insulin Best in Pregnant Type 1 Diabetics
MDedge Family Medicine
Metabolic Factors May Link Diabetes, Morphea
MDedge Family Medicine
Duration of Bisphosphonate Therapy Frequently Extended in Paget's Disease
MDedge Family Medicine
Paget's Patients Develop Resistance to Pamidronate
MDedge Family Medicine
Clinical Capsules
MDedge Family Medicine
Hyperglycemia, Not Diabetes, Is the Killer
MDedge Family Medicine
Hospitals Urged to Pursue Revised Glucose Control Targets
MDedge Family Medicine